Pfizer trims gains - Analysis - 13-12-2018

Pfizer's stock rose 0.34% in the last session, or 0.15 points, after marking an intraday high at 44.85, bouncing off it lower and trimming the gains, amid the dominance of the main upward short-term trend, with positive pressure from the 50-day SMA, while the RSI reached oversold levels compared to the stock's movements. 

Therefore we expect more gains for the stock, as long as the support of 43.07 holds on, targeting the pivotal resistance of 46.37. 

Expected trend for today: Bullish